Please click here to obtain permission to reproduce this image.
Click on image to view larger version.

Figure 2 Unadjusted all-cause mortality survival curves for Treatment trial participants. Patients receiving neither enalapril nor a beta-blocker (neither) are represented by the broken gray line, those receiving enalapril alone by the solid gray line, patients receiving beta-blockers alone by the broken black line and those receiving both enalapril and a beta-blocker (both) by the solid black line. The number of patients at risk of death during each 365-day period is shown.
|